Russell Investments Group, Ltd. Gilead Sciences, Inc. Transaction History

Russell Investments Group, Ltd.

  • $60.3 Billion
  • Q2 2024

A detailed history of Russell Investments Group, Ltd. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 1,074,871 shares of GILD stock, worth $94.7 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
1,074,871
Previous 1,026,980 4.66%
Holding current value
$94.7 Million
Previous $75.2 Million 1.97%
% of portfolio
0.12%
Previous 0.12%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024
BUY
$63.15 - $72.88 $3.02 Million - $3.49 Million
47,891 Added 4.66%
1,074,871 $73.7 Million
Q1 2024

May 08, 2024
SELL
$71.58 - $87.29 $4 Million - $4.88 Million
-55,922 Reduced 5.16%
1,026,980 $75.2 Million
Q4 2023

Feb 05, 2024
SELL
$73.27 - $83.09 $15.3 Million - $17.4 Million
-209,199 Reduced 16.19%
1,082,902 $87.7 Million
Q3 2023

Nov 13, 2023
BUY
$73.94 - $80.67 $3.4 Million - $3.71 Million
45,984 Added 3.69%
1,292,101 $96.8 Million
Q2 2023

Aug 10, 2023
SELL
$76.01 - $86.7 $17.8 Million - $20.3 Million
-234,711 Reduced 15.85%
1,246,117 $96 Million
Q1 2023

May 09, 2023
SELL
$77.31 - $88.08 $731,120 - $832,972
-9,457 Reduced 0.63%
1,480,828 $123 Million
Q4 2022

Feb 08, 2023
SELL
$62.32 - $89.47 $17.9 Million - $25.7 Million
-287,801 Reduced 16.19%
1,490,285 $128 Million
Q3 2022

Nov 04, 2022
BUY
$59.54 - $68.01 $2.63 Million - $3 Million
44,171 Added 2.55%
1,778,086 $110 Million
Q2 2022

Jul 29, 2022
BUY
$57.72 - $65.01 $11.8 Million - $13.3 Million
203,842 Added 13.32%
1,733,915 $107 Million
Q1 2022

May 05, 2022
BUY
$57.92 - $72.58 $25.9 Million - $32.5 Million
447,449 Added 41.33%
1,530,073 $91 Million
Q4 2021

Jan 21, 2022
SELL
$64.88 - $73.64 $1.39 Million - $1.58 Million
-21,495 Reduced 1.95%
1,082,624 $78.7 Million
Q3 2021

Nov 08, 2021
SELL
$67.69 - $73.03 $8.65 Million - $9.33 Million
-127,745 Reduced 10.37%
1,104,119 $77.5 Million
Q2 2021

Aug 04, 2021
BUY
$63.47 - $69.35 $3.2 Million - $3.5 Million
50,431 Added 4.27%
1,231,864 $84.6 Million
Q1 2021

May 10, 2021
SELL
$60.0 - $68.46 $11.5 Million - $13.1 Million
-191,659 Reduced 13.96%
1,181,433 $76.6 Million
Q4 2020

Feb 08, 2021
BUY
$56.65 - $64.55 $712,090 - $811,393
12,570 Added 0.92%
1,373,092 $79.1 Million
Q3 2020

Nov 09, 2020
BUY
$62.1 - $78.08 $13.5 Million - $16.9 Million
216,712 Added 18.95%
1,360,522 $85.4 Million
Q2 2020

Aug 05, 2020
SELL
$72.34 - $84.0 $139,905 - $162,456
-1,934 Reduced 0.17%
1,143,810 $86.9 Million
Q1 2020

May 06, 2020
SELL
$62.63 - $80.22 $84.5 Million - $108 Million
-1,349,280 Reduced 54.08%
1,145,744 $86.1 Million
Q4 2019

Jan 29, 2020
BUY
$61.62 - $67.78 $727,978 - $800,752
11,814 Added 0.48%
2,495,024 $162 Million
Q3 2019

Nov 01, 2019
BUY
$62.51 - $69.0 $7.88 Million - $8.69 Million
125,993 Added 5.34%
2,483,210 $157 Million
Q2 2019

Aug 09, 2019
BUY
$61.87 - $69.38 $7.43 Million - $8.33 Million
120,030 Added 5.37%
2,357,217 $159 Million
Q1 2019

May 13, 2019
BUY
$62.53 - $70.05 $16 Million - $17.9 Million
255,632 Added 12.9%
2,237,187 $144 Million
Q4 2018

Feb 11, 2019
BUY
$60.54 - $79.0 $410,763 - $536,015
6,785 Added 0.34%
1,981,555 $123 Million
Q3 2018

Oct 26, 2018
BUY
$71.28 - $78.92 $6.78 Million - $7.51 Million
95,171 Added 5.06%
1,974,770 $152 Million
Q2 2018

Aug 08, 2018
SELL
$64.88 - $75.68 $11 Million - $12.8 Million
-168,881 Reduced 8.24%
1,879,599 $133 Million
Q1 2018

May 11, 2018
SELL
$72.84 - $88.8 $22.8 Million - $27.8 Million
-312,699 Reduced 13.24%
2,048,480 $154 Million
Q4 2017

Feb 06, 2018
BUY
$71.15 - $83.52 $64.9 Million - $76.2 Million
912,621 Added 63.0%
2,361,179 $171 Million
Q3 2017

Nov 07, 2017
BUY
$72.11 - $85.47 $104 Million - $124 Million
1,448,558
1,448,558 $117 Million

Others Institutions Holding GILD

# of Institutions
1,893
Shares Held
1.02B
Call Options Held
12M
Put Options Held
9.04M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email